UVI5008: the first reversible, non-covalent Bruton's tyrosine kinase epi-inhibitor for B-cell malignancies
UVI5008:首个用于治疗B细胞恶性肿瘤的可逆性非共价布鲁顿酪氨酸激酶表观抑制剂
期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-026-01784-9
Dell'Aversana, Carmela; Sgueglia, G; Massaro, C; Perricone, U; Sarno, F; Megchelenbrink, W L; Conte, M; Carafa, V; Campanella, A; Frenquelli, M; Bordini, J; Ghia, P; Petrizzi, V B; Alvarez, R; Nappi, D; Chiurazzi, F; Tambaro, F P; Wierda, W G; de Lera, A R; Altucci, Lucia
B细胞
肿瘤
表观遗传
肿瘤免疫
信号转导
细胞生物学
免疫/内分泌